Table 3.
Intratumoral ZBTB20 | Peritumoral ZBTB20 | |||||
---|---|---|---|---|---|---|
Variable | High (n = 42, 41.2%) |
Low (n = 60, 58.8%) |
P | High (n = 42, 41.2%) |
Low (n = 60, 58.8%) |
P |
Age(years) | 0.523 | 1.0 | ||||
≤50 | 19 | 31 | 20 | 30 | ||
>50 | 23 | 29 | 22 | 30 | ||
Gender | 0.188 | 0.188 | ||||
Male | 36 | 45 | 36 | 45 | ||
Female | 6 | 15 | 6 | 15 | ||
Tumor size(mm) | 0.299 | 0.550 | ||||
≤50 | 10 | 20 | 11 | 19 | ||
>50 | 32 | 40 | 31 | 41 | ||
AFP(ng/ml) | ||||||
≤20 | 10 | 16 | 0.745 | 11 | 15 | 0.892 |
>20 | 32 | 44 | 31 | 45 | ||
HBsAg | 0.302 | 0.106 | ||||
Positive | 38 | 50 | 39 | 49 | ||
Negtive | 4 | 10 | 3 | 11 | ||
Pathological stage | 0.396* | 1.0* | ||||
I-II | 1 | 5 | 2 | 4 | ||
III-IV | 41 | 55 | 40 | 56 | ||
Liver cirrhosis | 0.675 | 0.172 | ||||
Yes | 31 | 42 | 27 | 46 | ||
No | 11 | 18 | 15 | 14 | ||
Tumor encapsulation | 0.235 | 0.446 | ||||
Complete | 12 | 27 | 13 | 26 | ||
Uncomplete | 10 | 10 | 9 | 11 | ||
No | 20 | 23 | 20 | 23 | ||
Vein invasion | 0.016 | 0.161 | ||||
Present | 13 | 7 | 11 | 9 | ||
Absent | 29 | 53 | 31 | 51 | ||
Tumour multiplicity | 0.064 | 0.589 | ||||
Solitary | 25 | 46 | 28 | 43 | ||
Multiple | 17 | 14 | 14 | 17 | ||
TNM stage | 0.07 | 0.573 | ||||
I-II | 22 | 5 | 25 | 39 | ||
III | 20 | 55 | 17 | 21 | ||
Recurrence | 0.003 | 0.001 | ||||
Yes | 37 | 37 | 38 | 36 | ||
No | 5 | 23 | 4 | 24 | ||
Metastasis | 0.000 | 0.08 | ||||
Yes | 27 | 16 | 22 | 21 | ||
No | 15 | 44 | 20 | 39 |
Abbreviations: HBsAg, hepatitis B s antigen.
*Twenty-five percent of all the cells have expected count less than 5; Fisher's exact test.